Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif

Clinical trial NCT02377323 · COMPLETED

Trial details

NCT number: NCT02377323
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2014-01-01
Primary completion: 2015-05-01
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.